Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbott Labs says it will pay $170M upfront for experimental chronic pain drug from PanGenetics
Abbott Labs says it will pay $170M upfront for experimental chronic pain drug from PanGenetics
Abbott Labs says it will pay $170M upfront for experimental chronic pain drug from PanGenetics
Submitted by
admin
on November 12, 2009 - 10:49am
Source:
Yahoo/AP
News Tags:
PanGenetics
Abbott Laboratories
chronic pain
Headline:
Abbott Labs says it will pay $170M upfront for experimental chronic pain drug from PanGenetics
Do Not Allow Advertisers to Use My Personal information
